T0	Disease 81 84	CKD
#1	AnnotatorNotes T0	DOID:784
T11	Biomarker 684 701	lipase deficiency
T12	Drug 725 737	atorvastatin
T13	Disease 760 763	CKD
T15	Chemical 823 835	triglyceride
T17	Biomarker 1031 1051	hypertriglyceridemia
#7	AnnotatorNotes T17	D015228
T2	Chemical 130 143	triglycerides
T21	Biomarker 1133 1148	LCAT deficiency
T23	Chemical 1215 1245	triglyceride-rich lipoproteins
T25	Drug 1366 1378	atorvastatin
T26	Disease 1387 1390	CKD
T27	Drug-Class 1474 1481	statins
T28	Chemical 1538 1550	triglyceride
T29	Disease 1554 1578	nonuremic hyperlipidemic
T30	Disease 1632 1635	CKD
T31	Disease 1677 1691	hyperlipidemic
T4	Chemical 189 202	triglycerides
T5	Disease 253 256	CKD
T7	Disease 459 462	CKD
T9	Disease 616 648	CKD-induced hypertriglyceridemia
#24	AnnotatorNotes T9	not found
T1	Biomarker 111 166	elevation of serum triglycerides, NEFA, and VLDL levels
T3	Chemical 145 149	NEFA
T6	Chemical 155 159	VLDL
R1	Association Arg1:T1 Arg2:T0	
T8	Biomarker 181 249	hepatic triglycerides and NEFA levels were also significantly higher
T14	Chemical 207 211	NEFA
R2	Association Arg1:T8 Arg2:T5	
T16	Gene-Protein 315 321	lipase
T18	Biomarker 290 440	significant reduction in lipase enzyme activity and protein expression in the liver (hepatic lipase), heart, skeletal muscle, adipose tissue and serum
T20	Gene-Protein 375 389	hepatic lipase
T32	Biomarker 496 527	downregulation of VLDL receptor
T33	Chemical 514 518	VLDL
T34	Gene-Protein 514 527	VLDL receptor
R3	Association Arg1:T32 Arg2:T7	
T10	Gene-Protein 685 690	ipase
R4	Association Arg1:T11 Arg2:T9	
#2	AnnotatorNotes T12	CHEMBL1487
T35	Chemical 840 844	NEFA
T36	Chemical 870 874	VLDL
T37	Gene-Protein 927 933	lipase
T19	Biomarker 1083 1120	impaired maturation of HDL-3 to HDL-2
T38	Chemical 1106 1111	HDL-3
T39	Chemical 1115 1120	HDL-2
T40	Gene-Protein 1133 1137	LCAT
T41	Collection 1083 1148	impaired maturation of HDL-3 to HDL-2 mediated by LCAT deficiency
T22	Chemical 1252 1256	VLDL
T42	Chemical 1261 1273	chylomicrons
T43	Chemical 1525 1528	LDL
T44	Chemical 1530 1533	HDL
#4	AnnotatorNotes T29	not found
#5	AnnotatorNotes T31	D015228
T45	Chemical 1431 1434	HDL
T46	Disease 1055 1058	CKD
T60	Biomarker 1416 1445	improvement in HDL metabolism
T61	Biomarker 1519 1550	serum LDL, HDL and triglyceride
T52	Biomarker 794 851	decline in serum and hepatic triglyceride and NEFA levels
T53	Biomarker 864 881	serum VLDL levels
T47	Biomarker 1215 1289	triglyceride-rich lipoproteins (i.e. VLDL and chylomicrons) in circulation
T48	Biomarker 1178 1197	defective lipolysis
T24	Biomarker 1323 1358	improvement in hypertriglyceridemia
R5	Response Arg1:T27 Arg2:T29	
